Core Scientific (NASDAQ:CORZ) Given New $19.00 Price Target at BTIG Research

Core Scientific (NASDAQ:CORZGet Free Report) had its target price increased by research analysts at BTIG Research from $15.00 to $19.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. BTIG Research’s target price would indicate a potential upside of 23.30% from the company’s previous close.

CORZ has been the subject of a number of other research reports. Canaccord Genuity Group reissued a “buy” rating and issued a $17.00 price target on shares of Core Scientific in a report on Thursday, November 7th. Roth Mkm initiated coverage on shares of Core Scientific in a research report on Friday. They set a “buy” rating and a $25.50 price target for the company. B. Riley upped their price target on shares of Core Scientific from $16.00 to $17.00 and gave the company a “buy” rating in a report on Thursday, November 7th. Needham & Company LLC raised their price objective on shares of Core Scientific from $17.00 to $18.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. Finally, HC Wainwright upped their target price on shares of Core Scientific from $15.00 to $17.00 and gave the company a “buy” rating in a research note on Thursday, November 7th. Thirteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Core Scientific presently has an average rating of “Buy” and an average target price of $18.38.

Get Our Latest Research Report on CORZ

Core Scientific Trading Down 0.2 %

NASDAQ:CORZ traded down $0.03 during mid-day trading on Friday, hitting $15.41. The company had a trading volume of 3,812,568 shares, compared to its average volume of 8,871,831. The business has a fifty day simple moving average of $12.76 and a 200-day simple moving average of $9.72. The firm has a market capitalization of $4.30 billion and a price-to-earnings ratio of -2.84. Core Scientific has a 1 year low of $2.61 and a 1 year high of $18.03.

Insider Buying and Selling

In other news, Director Jarrod M. Patten bought 4,000 shares of the stock in a transaction that occurred on Wednesday, August 28th. The shares were acquired at an average cost of $9.70 per share, for a total transaction of $38,800.00. Following the purchase, the director now owns 279,239 shares of the company’s stock, valued at $2,708,618.30. This represents a 1.45 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Over the last three months, insiders acquired 12,761 shares of company stock worth $127,080. Corporate insiders own 32.00% of the company’s stock.

Institutional Trading of Core Scientific

Hedge funds have recently bought and sold shares of the stock. Banque Cantonale Vaudoise bought a new stake in Core Scientific in the 2nd quarter valued at $28,000. Aspect Partners LLC bought a new stake in Core Scientific in the first quarter valued at about $29,000. Sunbelt Securities Inc. acquired a new position in shares of Core Scientific in the 2nd quarter worth approximately $33,000. Rise Advisors LLC bought a new position in shares of Core Scientific during the second quarter valued at $65,000. Finally, Divisadero Street Capital Management LP acquired a new position in Core Scientific in the second quarter valued at about $93,000.

About Core Scientific

(Get Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

See Also

Analyst Recommendations for Core Scientific (NASDAQ:CORZ)

Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.